Unbiased evaluation of rapamycin's specificity as an mTOR inhibitor

Artoni, F.; Grützmacher, N.; Demetriades, C.

doi:10.1111/acel.13888

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Unbiased evaluation of rapamycin's specificity as an mTOR inhibitor

MPS-Authors

/persons/resource/persons285163

Artoni, F.
Demetriades – Cell Growth Control in Health and Age-related Disease, Max Planck Research Groups, Max Planck Institute for Biology of Ageing, Max Planck Society;

/persons/resource/persons284253

Grützmacher, N.
Demetriades – Cell Growth Control in Health and Age-related Disease, Max Planck Research Groups, Max Planck Institute for Biology of Ageing, Max Planck Society;

/persons/resource/persons278102

Demetriades, C.
Demetriades – Cell Growth Control in Health and Age-related Disease, Max Planck Research Groups, Max Planck Institute for Biology of Ageing, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Artoni, F., Grützmacher, N., & Demetriades, C. (2023). Unbiased evaluation of rapamycin's specificity as an mTOR inhibitor. Aging Cell. doi:10.1111/acel.13888.

Cite as: https://hdl.handle.net/21.11116/0000-000D-3282-7

Abstract

There is no abstract available